The predictability of renin–angiotensin–aldosterone system factors for clinical outcome in patients with acute decompensated heart failure

Heart and Vessels

Volumn 31, Issue 6, 2016, Pages 925-931

  Nakada, Yasuki ^a,b   Takahama, Hiroyuki ^a   Kanzaki, Hideaki ^a   Sugano, Yasuo ^a   Hasegawa, Takuya ^a   Ohara, Takahiro ^a   Amaki, Makoto ^a   Funada, Akira ^a   Yoshida, Akemi ^a   Yasuda, Satoshi ^a   Ogawa, Hisao ^a   Anzai, Toshihisa ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Acute decompensated heart failure; BNP; Renin angiotensin aldosterone system

Indexed keywords

ALDOSTERONE; ALDOSTERONE ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; BIOLOGICAL MARKER; RENIN;

ACUTE HEART FAILURE; AGED; ALDOSTERONE BLOOD LEVEL; AREA UNDER THE CURVE; ARTICLE; DIASTOLIC BLOOD PRESSURE; FEMALE; HEMODYNAMICS; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE; URINE VOLUME; VERY ELDERLY; WEIGHT REDUCTION; ACUTE DISEASE; BLOOD; EVALUATION STUDY; HEART FAILURE; JAPAN; MIDDLE AGED; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; TREATMENT OUTCOME; UPREGULATION;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ALDOSTERONE; AREA UNDER CURVE; BIOMARKERS; FEMALE; HEART FAILURE; HEMODYNAMICS; HUMANS; JAPAN; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; RENIN; RENIN-ANGIOTENSIN SYSTEM; RETROSPECTIVE STUDIES; ROC CURVE; TREATMENT OUTCOME; UP-REGULATION;

EID: 84929179739     PISSN: 09108327     EISSN: 16152573     Source Type: Journal    
DOI: 10.1007/s00380-015-0688-7     Document Type: Article

References (39)

1. Wilson JR, Schwartz JS, Sutton MS, Ferraro N, Horowitz LN, Reichek N, Josephson ME (1983) Prognosis in severe heart failure: relation to hemodynamic measurements and ventricular ectopic activity. J Am Coll Cardiol 2:403–410
2. Ishii S, Inomata T, Ikeda Y, Nabeta T, Iwamoto M, Watanabe I, Naruke T, Shinagawa H, Koitabashi T, Nishii M, Takeuchi I, Izumi T (2014) Clinical significance of heart rate during acute decompensated heart failure to predict left ventricular reverse remodeling and prognosis in response to therapies in nonischemic dilated cardiomyopathy. Heart Vessels 29:88–96
3. Gheorghiade M, Pang PS (2009) Acute heart failure syndromes. J Am Coll Cardiol 53:557–573
4. Swedberg K, Eneroth P, Kjekshus J, Wilhelmsen L (1990) Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. Consensus trial study group. Circulation 82:1730–1736
5. Schrier RW, Abraham WT (1999) Hormones and hemodynamics in heart failure. N Engl J Med 341:577–585
6. Cohn JN (2010) Role of the renin-angiotensin system in cardiovascular disease. Cardiovasc Drugs Ther 24:341–344
7. Beygui F, Collet JP, Benoliel JJ, Vignolles N, Dumaine R, Barthelemy O, Montalescot G (2006) High plasma aldosterone levels on admission are associated with death in patients presenting with acute st-elevation myocardial infarction. Circulation 114:2604–2610
8. Tomaschitz A, Pilz S, Ritz E, Morganti A, Grammer T, Amrein K, Boehm BO, Marz W (2011) Associations of plasma renin with 10-year cardiovascular mortality, sudden cardiac death, and death due to heart failure. Eur Heart J 32:2642–2649
9. Tomaschitz A, Pilz S, Ritz E, Grammer T, Drechsler C, Boehm BO, Marz W (2011) Association of plasma aldosterone with cardiovascular mortality in patients with low estimated gfr: the ludwigshafen risk and cardiovascular health (luric) study. Am J Kidney Dis 57:403–414
10. Nishiyama K, Tsutamoto T, Kawahara C, Yamaji M, Sakai H, Yamamoto T, Fujii M, Horie M (2011) Relationship between biological variation in b-type natriuretic peptide and plasma renin concentration in stable outpatients with dilated cardiomyopathy. Circ J 75:1897–1904
11. Nishikimi T, Maeda N, Matsuoka H (2006) The role of natriuretic peptides in cardioprotection. Cardiovasc Res 69:318–328
12. Hobbs RE, Mills RM (2008) Endogenous b-type natriuretic peptide: a limb of the regulatory response to acutely decompensated heart failure. Clin Cardiol 31:407–412
13. Latini R, Masson S, Anand I, Salio M, Hester A, Judd D, Barlera S, Maggioni AP, Tognoni G, Cohn JN (2004) The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in val-heft. Eur Heart J 25:292–299
14. Anand IS, Fisher LD, Chiang YT, Latini R, Masson S, Maggioni AP, Glazer RD, Tognoni G, Cohn JN (2003) Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the valsartan heart failure trial (val-heft). Circulation 107:1278–1283
15. Poletti R, Vergaro G, Zyw L, Prontera C, Passino C, Emdin M (2013) Prognostic value of plasma renin activity in heart failure patients with chronic kidney disease. Int J Cardiol 167:711–715
16. Tsutamoto T, Sakai H, Tanaka T, Fujii M, Yamamoto T, Wada A, Ohnishi M, Horie M (2007) Comparison of active renin concentration and plasma renin activity as a prognostic predictor in patients with heart failure. Circ J 71:915–921
17. de Boer RA, Schroten NF, Bakker SJ, Mahmud H, Szymanski MK, van der Harst P, Gansevoort RT, van Veldhuisen DJ, van Gilst WH, Hillege HL (2012) Plasma renin and outcome in the community: data from prevend. Eur Heart J 33:2351–2359
18. McCullough PA, Duc P, Omland T, McCord J, Nowak RM, Hollander JE, Herrmann HC, Steg PG, Westheim A, Knudsen CW, Storrow AB, Abraham WT, Lamba S, Wu AH, Perez A, Clopton P, Krishnaswamy P, Kazanegra R, Maisel AS (2003) B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the breathing not properly multinational study. Am J Kidney Dis 41:571–579
19. Li J, Wang L (2006) B-type natriuretic peptide levels in patients with paroxysmal lone atrial fibrillation. Heart Vessels 21:137–140
20. Takahama H, Yokoyama H, Kada A, Sekiguchi K, Fujino M, Funada A, Amaki M, Hasegawa T, Asakura M, Kanzaki H, Anzai T, Kitakaze M (2013) Extent of heart rate reduction during hospitalization using beta-blockers, not the achieved heart rate itself at discharge, predicts the clinical outcome in patients with acute heart failure syndromes. J Cardiol 61:58–64
21. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ (2005) Recommendations for chamber quantification: a report from the american society of echocardiography’s guidelines and standards committee and the chamber quantification writing group, developed in conjunction with the european association of echocardiography, a branch of the european society of cardiology. J Am Soc Echocardiogr 18:1440–1463
22. Teichholz LE, Kreulen T, Herman MV, Gorlin R (1976) Problems in echocardiographic volume determinations: echocardiographic–angiographic correlations in the presence of absence of asynergy. Am J Cardiol 37:7–11
23. Nakabo A, Goda A, Masaki M, Otsuka M, Yoshida C, Eguchi A, Hirotani S, Lee-Kawabata M, Tsujino T, Masuyama T (2014) The impairment of the parasympathetic modulation is involved in the age-related change in mitral e/a ratio. Heart Vessels 29:343–353
24. Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A (2009) Revised equations for estimated gfr from serum creatinine in Japan. Am J Kidney Dis 53:982–992
25. Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, Tajik AJ (2000) Clinical utility of doppler echocardiography and tissue doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous doppler-catheterization study. Circulation 102:1788–1794
26. Masson S, Solomon S, Angelici L, Latini R, Anand IS, Prescott M, Maggioni AP, Tognoni G, Cohn JN (2010) Elevated plasma renin activity predicts adverse outcome in chronic heart failure, independently of pharmacologic therapy: data from the valsartan heart failure trial (val-heft). J Card Fail 16:964–970
27. Johnson W, Omland T, Hall C, Lucas C, Myking OL, Collins C, Pfeffer M, Rouleau JL, Stevenson LW (2002) Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class iv heart failure. J Am Coll Cardiol 39:1623–1629
28. Dzau V (2005) The cardiovascular continuum and renin–angiotensin–aldosterone system blockade. J Hypertens Suppl 23:S9–S17
29. Schroten NF, Gaillard CA, van Veldhuisen DJ, Szymanski MK, Hillege HL, de Boer RA (2012) New roles for renin and prorenin in heart failure and cardiorenal crosstalk. Heart Fail Rev 17:191–201
30. Rademaker MT, Yandle TG, Ellmers LJ, Charles CJ, Nicholls MG, Richards AM (2012) Hemodynamic, hormonal, and renal effects of (pro)renin receptor blockade in experimental heart failure. Circ Heart Fail. 5:645–652
31. Melnyk RA, Tam J, Boie Y, Kennedy BP, Percival MD (2009) Renin and prorenin activate pathways implicated in organ damage in human mesangial cells independent of angiotensin ii production. Am J Nephrol 30:232–243
32. Weir RA, Tsorlalis IK, Steedman T, Dargie HJ, Fraser R, McMurray JJ, Connell JM (2011) Aldosterone and cortisol predict medium-term left ventricular remodelling following myocardial infarction. Eur J Heart Fail 13:1305–1313
33. Tomaschitz A, Ritz E, Pieske B, Fahrleitner-Pammer A, Kienreich K, Horina JH, Drechsler C, Marz W, Ofner M, Pieber TR, Pilz S (2012) Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease. Cardiovasc Res 94:10–19
34. Ferrario CM, Strawn WB (2006) Role of the renin–angiotensin–aldosterone system and proinflammatory mediators in cardiovascular disease. Am J Cardiol 98:121–128
35. Vergaro G, Emdin M, Iervasi A, Zyw L, Gabutti A, Poletti R, Mammini C, Giannoni A, Fontana M, Passino C (2011) Prognostic value of plasma renin activity in heart failure. Am J Cardiol 108:246–251
36. Tomaschitz A, Pilz S, Ritz E, Meinitzer A, Boehm BO, Marz W (2010) Plasma aldosterone levels are associated with increased cardiovascular mortality: the ludwigshafen risk and cardiovascular health (luric) study. Eur Heart J 31:1237–1247
37. Tomaschitz A, Pilz S, Pieske B, Ritz E, Marz W, Meinitzer A, Dobnig H, Amrein K, Kienreich K, Verheyen N, Kraigher-Krainer E, Drechsler C, Colantonio C, Wagner D, Fahrleitner-Pammer A (2013) Circulating aldosterone and mortality in female nursing home residents. Exp Gerontol 48:313–318
38. Fonarow GC, Adams KF Jr, Abraham WT, Yancy CW, Boscardin WJ (2005) Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 293:572–580
39. Miura M, Sakata Y, Nochioka K, Takahashi J, Takada T, Miyata S, Hiramoto T, Inoue K, Tamaki K, Shiba N, Shimokawa H (2013) Prognostic impact of blood urea nitrogen changes during hospitalization in patients with acute heart failure syndrome. Circ J 77:1221–1228